Antihypertensive effectiveness of combination therapy with losartan/hydrochlorothiazide for 'real world' management of isolated systolic hypertension
Conclusions:
Lo/HTCZ is safe and effective in reducing and improving BP control in a ‘real world’ setting. Treatment with Lo/HTCZ enabled a substantial proportion of hypertensive patients with associated diseases to achieve the recommended goal of <140 mm Hg.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Suzuki, H., Shimada, K., Fujiwara, K. Tags: Original Research Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Cozaar | Databases & Libraries | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Disease | Hydrochlorothiazide | Hypertension | Laboratory Medicine | Losartan | Obesity | Study | Urology & Nephrology